Non-productive HIV-1 infection of human glomerular and urinary podocytes

Virology

Volumn 408, Issue 1, 2010, Pages 119-127

  Khatua, Atanu K ^a   Taylor, Harry E ^a   Hildreth, James E K ^a   Popik, Waldemar ^a  

^a MEHARRY MEDICAL COLLEGE   (United States)

Author keywords

Endocytosis; HIV 1; HIVAN; Podocyte

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; DYNAMIN; NUCLEIC ACID; T LYMPHOCYTE RECEPTOR;

ARTICLE; CONTROLLED STUDY; ENDOCYTOSIS; GENETIC TRANSFECTION; GLOMERULUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IN VITRO STUDY; INTERNALIZATION; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; URINE LEVEL; VIRUS ENTRY; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS TYPING;

CELL LINE; ENDOCYTOSIS; HIV-1; HUMANS; PODOCYTES; RECEPTORS, HIV; VIRUS INTERNALIZATION; VIRUS RELEASE; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1; VESICULAR STOMATITIS VIRUS;

EID: 78049240369     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.09.005     Document Type: Article

References (54)

1. Akilesh S., Huber T.B., Wu H., Wang G., Hartleben B., Kopp J.B., Miner J.H., Roopenian D.C., Unanue E.R., Shaw A.S. Podocytes use FcRn to clear IgG from the glomerular basement membrane. Proc. Natl Acad. Sci. USA 2008, 105(3):967-972.
2. Ali, S.A., Huang, M.B., Campbell, P.E., Roth, W.W., Campbell, T., Khan, M., Newman, G., Villinger, F., Powell, M.D., and Bond, V.C., 2010. Genetic characterization of HIV type 1 Nef-induced vesicle secretion. AIDS Res. Hum. Retroviruses 26(2), 173-92.
3. Atta M.G., Deray G., Lucas G.M. Antiretroviral nephrotoxicities. Semin. Nephrol. 2008, 28(6):563-575.
4. Bruggeman L.A., Ross M.D., Tanji N., Cara A., Dikman S., Gordon R.E., Burns G.C., D'Agati V.D., Winston J.A., Klotman M.E., Klotman P.E. Renal epithelium is a previously unrecognized site of HIV-1 infection. J. Am. Soc. Nephrol. 2000, 11(11):2079-2087.
5. Campbell E.M., Perez O., Melar M., Hope T.J. Labeling HIV-1 virions with two fluorescent proteins allows identification of virions that have productively entered the target cell. Virology 2007, 360(2):286-293.
6. Dezzutti C.S., Guenthner P.C., Cummins J.E., Cabrera T., Marshall J.H., Dillberger A., Lal R.B. Cervical and prostate primary epithelial cells are not productively infected but sequester human immunodeficiency virus type 1. J. Infect. Dis. 2001, 183(8):1204-1213.
7. Dowling D., Nasr-Esfahani S., Tan C.H., O'Brien K., Howard J.L., Jans D.A., Purcell D.F., Stoltzfus C.M., Sonza S. HIV-1 infection induces changes in expression of cellular splicing factors that regulate alternative viral splicing and virus production in macrophages. Retrovirology 2008, 5:18.
8. Eitner F., Cui Y., Hudkins K.L., Stokes M.B., Segerer S., Mack M., Lewis P.L., Abraham A.A., Schlondorff D., Gallo G., Kimmel P.L., Alpers C.E. Chemokine receptor CCR5 and CXCR4 expression in HIV-associated kidney disease. J. Am. Soc. Nephrol. 2000, 11(5):856-867.
9. Eyre J., Ioannou K., Grubb B.D., Saleem M.A., Mathieson P.W., Brunskill N.J., Christensen E.I., Topham P.S. Statin-sensitive endocytosis of albumin by glomerular podocytes. Am. J. Physiol. Ren. Physiol. 2007, 292(2):F674-F681.
10. Geijtenbeek T.B., Kwon D.S., Torensma R., van Vliet S.J., van Duijnhoven G.C., Middel J., Cornelissen I.L., Nottet H.S., KewalRamani V.N., Littman D.R., Figdor C.G., van Kooyk Y. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000, 100(5):587-597.
11. Geijtenbeek T.B., Torensma R., van Vliet S.J., van Duijnhoven G.C., Adema G.J., van Kooyk Y., Figdor C.G. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 2000, 100(5):575-585.
12. Hatsukari I., Singh P., Hitosugi N., Messmer D., Valderrama E., Teichberg S., Chaung W., Gross E., Schmidtmayerova H., Singhal P.C. DEC-205-mediated internalization of HIV-1 results in the establishment of silent infection in renal tubular cells. J. Am. Soc. Nephrol. 2007, 18(3):780-787.
13. He J.C., Husain M., Sunamoto M., D'Agati V.D., Klotman M.E., Iyengar R., Klotman P.E. Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1, 2 pathways. J. Clin. Invest. 2004, 114(5):643-651.
14. Houzet L., Morichaud Z., Mougel M. Fully-spliced HIV-1 RNAs are reverse transcribed with similar efficiencies as the genomic RNA in virions and cells, but more efficiently in AZT-treated cells. Retrovirology 2007, 4:30.
15. Houzet L., Paillart J.C., Smagulova F., Maurel S., Morichaud Z., Marquet R., Mougel M. HIV controls the selective packaging of genomic, spliced viral and cellular RNAs into virions through different mechanisms. Nucleic Acids Res. 2007, 35(8):2695-2704.
16. Huber T.B., Reinhardt H.C., Exner M., Burger J.A., Kerjaschki D., Saleem M.A., Pavenstadt H. Expression of functional CCR and CXCR chemokine receptors in podocytes. J. Immunol. 2002, 168(12):6244-6252.
17. Husain M., D'Agati V.D., He J.C., Klotman M.E., Klotman P.E. HIV-1 Nef induces dedifferentiation of podocytes in vivo: a characteristic feature of HIVAN. AIDS 2005, 19(17):1975-1980.
18. Husain M., Gusella G.L., Klotman M.E., Gelman I.H., Ross M.D., Schwartz E.J., Cara A., Klotman P.E. HIV-1 Nef induces proliferation and anchorage-independent growth in podocytes. J. Am. Soc. Nephrol. 2002, 13(7):1806-1815.
19. Ina K., Kitamura H., Tatsukawa S., Takayama T., Fujikura Y. Glomerular podocyte endocytosis of the diabetic rat. J. Electron Microsc. (Tokyo) 2002, 51(4):275-279.
20. Khatua A.K., Taylor H.E., Hildreth J.E., Popik W. Exosomes packaging APOBEC3G confer human immunodeficiency virus resistance to recipient cells. J. Virol. 2009, 83(2):512-521.
21. Lenassi, M., Cagney, G., Liao, M., Vaupotic, T., Bartholomeeusen, K., Cheng, Y., Krogan, N.J., Plemenitas, A., and Peterlin, B.M., 2010. HIV Nef is secreted in exosomes and triggers apoptosis in bystander CD4+ T cells. Traffic 11(1), 110-22.
22. Liang C., Hu J., Russell R.S., Kameoka M., Wainberg M.A. Spliced human immunodeficiency virus type 1 RNA is reverse transcribed into cDNA within infected cells. AIDS Res. Hum. Retroviruses 2004, 20(2):203-211.
23. Liu N.Q., Lossinsky A.S., Popik W., Li X., Gujuluva C., Kriederman B., Roberts J., Pushkarsky T., Bukrinsky M., Witte M., Weinand M., Fiala M. Human immunodeficiency virus type 1 enters brain microvascular endothelia by macropinocytosis dependent on lipid rafts and the mitogen-activated protein kinase signaling pathway. J. Virol. 2002, 76(13):6689-6700.
24. Lu T.C., He J.C., Klotman P.E. Podocytes in HIV-associated nephropathy. Nephron Clin. Pract. 2007, 106(2):c67-c71.
25. Lu T.C., He J.C., Wang Z.H., Feng X., Fukumi-Tominaga T., Chen N., Xu J., Iyengar R., Klotman P.E. HIV-1 Nef disrupts the podocyte actin cytoskeleton by interacting with diaphanous interacting protein. J. Biol. Chem. 2008, 283(13):8173-8182.
26. Macia E., Ehrlich M., Massol R., Boucrot E., Brunner C., Kirchhausen T. Dynasore, a cell-permeable inhibitor of dynamin. Dev. Cell 2006, 10(6):839-850.
27. Mack M., Kleinschmidt A., Bruhl H., Klier C., Nelson P.J., Cihak J., Plachy J., Stangassinger M., Erfle V., Schlondorff D. Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection. Nat. Med. 2000, 6(7):769-775.
28. Marras D., Bruggeman L.A., Gao F., Tanji N., Mansukhani M.M., Cara A., Ross M.D., Gusella G.L., Benson G., D'Agati V.D., Hahn B.H., Klotman M.E., Klotman P.E. Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy. Nat. Med. 2002, 8(5):522-526.
29. Mbisa J.L., Barr R., Thomas J.A., Vandegraaff N., Dorweiler I.J., Svarovskaia E.S., Brown W.L., Mansky L.M., Gorelick R.J., Harris R.S., Engelman A., Pathak V.K. Human immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration. J. Virol. 2007, 81(13):7099-7110.
30. Mikulak, J., Teichberg, S., Arora, S., Kumar, D., Yadav, A., Salhan, D., Pullagura, S., Mathieson, P.W., Saleem, M.A., and Singhal, P.C., 2010. DC-specific ICAM-3-Grabbing Nonintegrin Mediates Internalization of HIV-1 into Human Podocytes. Am. J. Physiol. Ren. Physiol.
31. Mikulak J., Teichberg S., Faust T., Schmidtmayerova H., Singhal P.C. HIV-1 harboring renal tubular epithelial cell interaction with T cells results in T cell trans-infection. Virology 2009, 385(1):105-114.
32. Miyauchi K., Kim Y., Latinovic O., Morozov V., Melikyan G.B. HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes. Cell 2009, 137(3):433-444.
33. Muratori C., Cavallin L.E., Kratzel K., Tinari A., De Milito A., Fais S., D'Aloja P., Federico M., Vullo V., Fomina A., Mesri E.A., Superti F., Baur A.S. Massive secretion by T cells is caused by HIV Nef in infected cells and by Nef transfer to bystander cells. Cell Host Microbe 2009, 6(3):218-230.
34. Onafuwa-Nuga A.A., Telesnitsky A., King S.R. 7SL RNA, but not the 54-kd signal recognition particle protein, is an abundant component of both infectious HIV-1 and minimal virus-like particles. RNA 2006, 12(4):542-546.
35. Pasternak A.O., Adema K.W., Bakker M., Jurriaans S., Berkhout B., Cornelissen M., Lukashov V.V. Highly sensitive methods based on seminested real-time reverse transcription-PCR for quantitation of human immunodeficiency virus type 1 unspliced and multiply spliced RNA and proviral DNA. J. Clin. Microbiol. 2008, 46(7):2206-2211.
36. Petermann A.T., Krofft R., Blonski M., Hiromura K., Vaughn M., Pichler R., Griffin S., Wada T., Pippin J., Durvasula R., Shankland S.J. Podocytes that detach in experimental membranous nephropathy are viable. Kidney Int. 2003, 64(4):1222-1231.
37. Popik W., Pitha P.M. Inhibition of CD3/CD28-mediated activation of the MEK/ERK signaling pathway represses replication of X4 but not R5 human immunodeficiency virus type 1 in peripheral blood CD4(+) T lymphocytes. J. Virol. 2000, 74(6):2558-2566.
38. Rahmoune H., Thompson P.W., Ward J.M., Smith C.D., Hong G., Brown J. Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes. Diabetes 2005, 54(12):3427-3434.
39. Rastaldi M.P., Armelloni S., Berra S., Calvaresi N., Corbelli A., Giardino L.A., Li M., Wang G.Q., Fornasieri A., Villa A., Heikkila E., Soliymani R., Boucherot A., Cohen C.D., Kretzler M., Nitsche A., Ripamonti M., Malgaroli A., Pesaresi M., Forloni G.L., Schlondorff D., Holthofer H., D'Amico G. Glomerular podocytes contain neuron-like functional synaptic vesicles. FASEB J. 2006, 20(7):976-978.
40. Rosenstiel P., Gharavi A., D'Agati V., Klotman P. Transgenic and infectious animal models of HIV-associated nephropathy. J. Am. Soc. Nephrol. 2009, 20(11):2296-2304.
41. Rossio J.L., Esser M.T., Suryanarayana K., Schneider D.K., Bess J.W., Vasquez G.M., Wiltrout T.A., Chertova E., Grimes M.K., Sattentau Q., Arthur L.O., Henderson L.E., Lifson J.D. Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins. J. Virol. 1998, 72(10):7992-8001.
42. Rozmyslowicz T., Majka M., Kijowski J., Murphy S.L., Conover D.O., Poncz M., Ratajczak J., Gaulton G.N., Ratajczak M.Z. Platelet- and megakaryocyte-derived microparticles transfer CXCR4 receptor to CXCR4-null cells and make them susceptible to infection by X4-HIV. AIDS 2003, 17(1):33-42.
43. Sakairi T., Abe Y., Kajiyama H., Bartlett L.D., Howard L.V., Jat P.S., Kopp J.B. Conditionally immortalized human podocyte cell lines established from urine. Am. J. Physiol. Ren. Physiol. 2010, 298(3):F557-F567.
44. Saleem M.A., O'Hare M.J., Reiser J., Coward R.J., Inward C.D., Farren T., Xing C.Y., Ni L., Mathieson P.W., Mundel P. A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J. Am. Soc. Nephrol. 2002, 13(3):630-638.
45. Schmid H., Henger A., Cohen C.D., Frach K., Grone H.J., Schlondorff D., Kretzler M. Gene expression profiles of podocyte-associated molecules as diagnostic markers in acquired proteinuric diseases. J. Am. Soc. Nephrol. 2003, 14(11):2958-2966.
46. Sunamoto M., Husain M., He J.C., Schwartz E.J., Klotman P.E. Critical role for Nef in HIV-1-induced podocyte dedifferentiation. Kidney Int. 2003, 64(5):1695-1701.
47. Vacharaksa A., Asrani A.C., Gebhard K.H., Fasching C.E., Giacaman R.A., Janoff E.N., Ross K.F., Herzberg M.C. Oral keratinocytes support non-replicative infection and transfer of harbored HIV-1 to permissive cells. Retrovirology 2008, 5:66.
48. Vidricaire G., Tremblay M.J. A clathrin, caveolae, and dynamin-independent endocytic pathway requiring free membrane cholesterol drives HIV-1 internalization and infection in polarized trophoblastic cells. J. Mol. Biol. 2007, 368(5):1267-1283.
49. Vogelmann S.U., Nelson W.J., Myers B.D., Lemley K.V. Urinary excretion of viable podocytes in health and renal disease. Am. J. Physiol. Ren. Physiol. 2003, 285(1):F40-F48.
50. Winston J.A., Bruggeman L.A., Ross M.D., Jacobson J., Ross L., D'Agati V.D., Klotman P.E., Klotman M.E. Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N Engl J. Med. 2001, 344(26):1979-1984.
51. Yang Y., Gubler M.C., Beaufils H. Dysregulation of podocyte phenotype in idiopathic collapsing glomerulopathy and HIV-associated nephropathy. Nephron 2002, 91(3):416-423.
52. Yu D., Petermann A., Kunter U., Rong S., Shankland S.J., Floege J. Urinary podocyte loss is a more specific marker of ongoing glomerular damage than proteinuria. J. Am. Soc. Nephrol. 2005, 16(6):1733-1741.
53. Zhang H., Zhou Y., Alcock C., Kiefer T., Monie D., Siliciano J., Li Q., Pham P., Cofrancesco J., Persaud D., Siliciano R.F. Novel single-cell-level phenotypic assay for residual drug susceptibility and reduced replication capacity of drug-resistant human immunodeficiency virus type 1. J. Virol. 2004, 78(4):1718-1729.
54. Zuo Y., Matsusaka T., Zhong J., Ma J., Ma L.J., Hanna Z., Jolicoeur P., Fogo A.B., Ichikawa I. HIV-1 genes vpr and nef synergistically damage podocytes, leading to glomerulosclerosis. J. Am. Soc. Nephrol. 2006, 17(10):2832-2843.